$OMER what is a company worth that owns the whole MASP2 space and about to have approved compliment drug in that space than add another compliment drug in MASP3? If the rumors were right that Biogen offered $28 per share, I understand Dr refused it!! Does any compliment company have the pipeline of the company I am talking about?
  • 14
  • 1
14 Likes